BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 32045679)

  • 1. Breast cancer models: Engineering the tumor microenvironment.
    Bahcecioglu G; Basara G; Ellis BW; Ren X; Zorlutuna P
    Acta Biomater; 2020 Apr; 106():1-21. PubMed ID: 32045679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology.
    Trivedi P; Liu R; Bi H; Xu C; Rosenholm JM; Åkerfelt M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment.
    Berger Fridman I; Kostas J; Gregus M; Ray S; Sullivan MR; Ivanov AR; Cohen S; Konry T
    Acta Biomater; 2021 Sep; 132():473-488. PubMed ID: 34153511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D bioprinting complex models of cancer.
    Sharma R; Restan Perez M; da Silva VA; Thomsen J; Bhardwaj L; Andrade TAM; Alhussan A; Willerth SM
    Biomater Sci; 2023 May; 11(10):3414-3430. PubMed ID: 37000528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogels to model 3D in vitro microenvironment of tumor vascularization.
    Song HH; Park KM; Gerecht S
    Adv Drug Deliv Rev; 2014 Dec; 79-80():19-29. PubMed ID: 24969477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
    Hoarau-Véchot J; Rafii A; Touboul C; Pasquier J
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation.
    Chen Y; Xu L; Li W; Chen W; He Q; Zhang X; Tang J; Wang Y; Liu B; Liu J
    Biofabrication; 2022 Jan; 14(2):. PubMed ID: 34991080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions.
    Rodrigues J; Heinrich MA; Teixeira LM; Prakash J
    Trends Cancer; 2021 Mar; 7(3):249-264. PubMed ID: 33218948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
    Jung M; Ghamrawi S; Du EY; Gooding JJ; Kavallaris M
    Adv Healthc Mater; 2022 Dec; 11(24):e2200690. PubMed ID: 35866252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to bioprinting of in vitro cancer models.
    Yi HG
    Essays Biochem; 2021 Aug; 65(3):603-610. PubMed ID: 34028520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printed
    Chen H; Cheng Y; Wang X; Wang J; Shi X; Li X; Tan W; Tan Z
    Theranostics; 2020; 10(26):12127-12143. PubMed ID: 33204333
    [No Abstract]   [Full Text] [Related]  

  • 13. 3D Printing of Tissue Engineered Constructs for In Vitro Modeling of Disease Progression and Drug Screening.
    Vanderburgh J; Sterling JA; Guelcher SA
    Ann Biomed Eng; 2017 Jan; 45(1):164-179. PubMed ID: 27169894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D hydrogel-based microwell arrays as a tumor microenvironment model to study breast cancer growth.
    Casey J; Yue X; Nguyen TD; Acun A; Zellmer VR; Zhang S; Zorlutuna P
    Biomed Mater; 2017 Mar; 12(2):025009. PubMed ID: 28143999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Bioprinted Volumetric Tumor Microenvironments In Vitro.
    Li J; Parra-Cantu C; Wang Z; Zhang YS
    Trends Cancer; 2020 Sep; 6(9):745-756. PubMed ID: 32680649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Bioprinting: An Important Tool for Tumor Microenvironment Research.
    Li Y; Liu J; Xu S; Wang J
    Int J Nanomedicine; 2023; 18():8039-8057. PubMed ID: 38164264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Model of Tumor Microenvironment on Microfluidic Platform.
    Chung M; Ahn J; Son K; Kim S; Jeon NL
    Adv Healthc Mater; 2017 Aug; 6(15):. PubMed ID: 28544639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinting tumor models mimic the tumor microenvironment for drug screening.
    Mi X; Su Z; Yue X; Ren Y; Yang X; Qiang L; Kong W; Ma Z; Zhang C; Wang J
    Biomater Sci; 2023 May; 11(11):3813-3827. PubMed ID: 37052182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Dimensional Models as a New Frontier for Studying the Role of Proteoglycans in the Normal and Malignant Breast Microenvironment.
    Clegg J; Koch MK; Thompson EW; Haupt LM; Kalita-de Croft P; Bray LJ
    Front Cell Dev Biol; 2020; 8():569454. PubMed ID: 33163489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.